Enzymes for Food & Pharma

Enzymes for Pharmaceutical Industry

Pharmaceutical Enzymes are specially engineered proteins that catalyse biological reactions in living organisms. There are two different variants of Pharmaceutical enzymes that make them distinct from all the other kinds of chemical drugs. The enzymes of the first kind bind and precisely act on their targets with prominent affinity. The second kind of enzymes are catalytic that transforms various targeted molecules into required products. Ann Organic India Private Limited enzymes are tailored in such a way that makes drugs more potent, allowing to achieve therapeutic biochemistry in living beings that small molecules cannot.

Enzymes in Pharmaceutical Industry
We manufacture and supply world-class enzymes for the Pharmaceutical industry. We specialized in manufacturing the best pharmaceutical enzymes in the market. Our strong networks of dealers across India allows Ann Organic India Enzymes to emerge as a leading supplier for enzymes for drug manufacturing companies.

Even before the inception of biotechnology, enzymes and proteins were used as drugs. Enzymes bind with their targets very specifically and with high affinity. They convert multiple target molecules to the desired products by catalytic action, increasing the rate of chemical interconversions and metabolic processes. This property differentiates them from all other types of drugs. Biochemical diversity and the ease with which the enzyme concentration may be increased by environmental and genetic manipulation give the advantage of using enzymes of microbial origin. Enzymes that are used therapeutically have the great advantage of being economically viable and reliable. Due to high yields, they are easy for product modification and optimization. Digestive and metabolic enzymes can be used either alone or in permutation with other therapies for the treatment of a number of diseases such as leukemia, skin ulcers, cardiovascular diseases, Parkinson’s disease, inflammation, digestive disorders, pancreatic disorders, etc. They are also in use in the diagnosis, biochemical investigation, and monitoring of many alarming diseases.

Application of Enzymes in Drug Manufacturing
It is often thought that enzyme transformations (or biocatalysis), is a new and emerging technology in the manufacture of small molecule active pharmaceutical ingredients (APIs). In fact a relatively large number of pharmaceuticals already on the market contain intermediates produced by biocatalysis. An explosion in the number and quantities of enzymes available to the synthetic organic chemist has made biocatalysis an increasingly attractive and viable manufacturing option. As always, cost of goods and process productivity are key drivers of adoption. In addition, sustainability and the adoption of greener and safer technologies are also clear factors influencing manufacturing route selection today and going forward. Biocatalysis is a green technology, and life cycle analysis shows that the use of recombinant technologies plays a major part in maximising the sustainability benefit of a biocatalysed process compared to a traditional chemical process.